Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes is a research paper published in JNCI Cancer Spectrum (2024). On theSindex it has a DataRank of 0.345. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.345
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: U01 CA265735
NCI NIH HHS
Grant: R01 CA253475
NCI NIH HHS
Grant: P30 CA091842
National Institutes of Health
Grant: 5R01CA253475-02
Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective
National Institutes of Health
Grant: 5U01CA265735-04
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
Siteman Cancer Center
FWCI
2.70
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals